ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

Committee Kills Pay Raise Bill; Rauscher Probably Will Resign

September 17, 1976

NCI Community Intervention Trial Reports

March 10, 1995